Old Wine in New Bottles? Deuterium Switch (Replacing Hydrogen With Deuterium) Comes to Thoracic Oncology as Deuterated Lorlatinib (Deulorlatinib, TGRX-326) and Deuterated Osimertinib (Asandeutertinib, TY-9591) in ALK+ NSCLC and EGFR+ NSCLC, Respectively
1 Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange/Irvine, California; Chao Family Comprehensive Cancer Center, Orange/Irvine, Orange, California.
2 Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.
3 Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange/Irvine, California; Chao Family Comprehensive Cancer Center, Orange/Irvine, Orange, California. Electronic address: ignatiusou@gmail.com.